BioMed Research International / 2021 / Article / Tab 1 / Research Article
Safety Evaluation and Flow Modification in the Anterior Cerebral Artery after Pipeline Embolization Device Deployment across the Internal Carotid Artery Terminus Table 1 Baseline demographic data for all, group 1, and group 2 patients.
Characteristic All Group 1 ( ) Group 2 ( ) valueSex 0.52 M (%) 17 (35%) 5 (29.4%) 12 (38.7%) F (%) 31 (65%) 12 (71.0%) 19 (61.3%) Mean age in yrs 0.26 Hypertension (%) 12 (25%) 6 (35.3%) 6 (19.4%) 0.30 Diabetes (%) 4 (8.3%) 2 (11.8%) 2 (6.5%) 0.52 Smoking (%) 14 (29.2%) 3 (17.6%) 11 (35.5%) 0.32 Aneurysm size (mm) 0.08 Aneurysms at the ICAb (%) 15 (31.3%) 8 (47.0%) 7 (22.5%) 0.08 Treatment 0.15 PED (%) 32 (62.7%) 13 (76.5%) 19 (55.9%) PED+coil (%) 19 (37.3%) 4 (23.5%) 15 (44.1%) Aneurysm occlusion 0.008 Complete obliteration (%) 31 (60.8%) 6 (35.3%) 25 (73.5%) IAO (%) 20 (39.2%) 11 (64.7%) 9 (26.5%) Fate of A1 Occlusion (%) 11 (22.9%) — 11 (35.5%) Diminished flow (%) 20 (41.7%) — 20 (64.5%) No flow change (%) 17 (35.4%) 17 (100%) — I-A1/I-ICA (mean (SD)) 0.50 (0.12) 0.49 (0.11) 0.51 (0.12) 0.74 I-M1/I-ICA (mean (SD)) 0.76 (0.12) 0.77 (0.12) 0.76 (0.12) 0.78 I-A1/I-M1 (mean (SD)) 0.67 (0.19) 0.67 (0.22) 0.68 (0.17) 0.88 OR I-A1/C-A1 (mean (SD)) 0.92 (0.24) 0.91 (0.19) 0.93 (0.27) 0.81 sPED/I-ICA (mean (SD)) 1.11 (0.16) 1.19 (0.18) 1.06 (0.12) 0.006
yrs: years; M: male; F: female; ICAb: the internal carotid artery bifurcation; PED: pipeline embolization device; IAO: incomplete aneurysm occlusion; I-A1: ipsilateral-A1; I-ICA: ipsilateral internal carotid artery; SD: standard deviation; I-M1: ipsilateral-M1; OR: the odds ratio; C-A1: contralateral-A1; sPED: the PED size.